Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of NECTAR LIFESCIENCE. For more details, see the NECTAR LIFESCIENCE quarterly results and NECTAR LIFESCIENCE share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -2.5 |
No. of shares | m | 224.26 |
1 Week | % | -4.7 |
1 Month | % | 5.7 |
1 Year | % | 91.3 |
52 week H/L | Rs | 45.7/16.4 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
NECTAR LIFESCIENCE EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 31 | 21 | 30 | 48 | 34 | |
Low | Rs | 16 | 7 | 10 | 19 | 14 | |
Sales per share (Unadj.) | Rs | 109.4 | 93.2 | 59.0 | 63.0 | 58.0 | |
Earnings per share (Unadj.) | Rs | 2.1 | 1.4 | -3.3 | 1.1 | -1.1 | |
Diluted earnings per share | Rs | 2.1 | 1.4 | -3.3 | 1.1 | -1.1 | |
Cash flow per share (Unadj.) | Rs | 4.9 | 4.1 | -0.6 | 3.7 | 1.6 | |
Dividends per share (Unadj.) | Rs | 0.05 | 0.05 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.05 | 0.05 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.2 | 0.4 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 49.3 | 50.7 | 47.4 | 48.5 | 47.5 | |
Adj. book value per share | Rs | 49.3 | 50.7 | 47.4 | 48.5 | 47.5 | |
Shares outstanding (eoy) | m | 224.26 | 224.26 | 224.26 | 224.26 | 224.26 | |
Price / Sales ratio | x | 0.2 | 0.2 | 0.3 | 0.5 | 0.4 | |
Avg P/E ratio | x | 10.9 | 9.9 | -6.1 | 30.0 | -22.5 | |
P/CF ratio (eoy) | x | 4.7 | 3.4 | -34.2 | 9.2 | 15.6 | |
Price / Book Value ratio | x | 0.5 | 0.3 | 0.4 | 0.7 | 0.5 | |
Dividend payout | % | 2.4 | 3.5 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 5,208 | 3,145 | 4,452 | 7,507 | 5,434 | |
Total wages/salary | Rs m | 765 | 782 | 706 | 719 | 751 |
NECTAR LIFESCIENCE INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 24,529 | 20,899 | 13,229 | 14,121 | 13,008 | |
Other income | Rs m | 60 | 44 | 114 | 113 | 432 | |
Total revenues | Rs m | 24,589 | 20,943 | 13,342 | 14,235 | 13,440 | |
Gross profit | Rs m | 2,642 | 2,197 | 761 | 1,585 | 530 | |
Depreciation | Rs m | 633 | 608 | 603 | 570 | 591 | |
Interest | Rs m | 1,481 | 1,258 | 1,120 | 788 | 795 | |
Profit before tax | Rs m | 588 | 375 | -848 | 341 | -424 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 112 | 57 | -115 | 90 | -182 | |
Profit after tax | Rs m | 476 | 318 | -733 | 250 | -242 | |
Gross profit margin | % | 10.8 | 10.5 | 5.8 | 11.2 | 4.1 | |
Effective tax rate | % | 19.1 | 15.2 | 13.6 | 26.5 | 43.0 | |
Net profit margin | % | 1.9 | 1.5 | -5.5 | 1.8 | -1.9 |
NECTAR LIFESCIENCE BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 16,690 | 16,152 | 12,388 | 13,549 | 12,312 | |
Current liabilities | Rs m | 12,999 | 12,479 | 11,874 | 10,038 | 8,909 | |
Net working cap to sales | % | 15.0 | 17.6 | 3.9 | 24.9 | 26.2 | |
Current ratio | x | 1.3 | 1.3 | 1.0 | 1.3 | 1.4 | |
Inventory Days | Days | 17 | 21 | 74 | 58 | 56 | |
Debtors Days | Days | 83 | 69 | 103 | 116 | 78 | |
Net fixed assets | Rs m | 10,360 | 10,181 | 11,370 | 10,332 | 9,375 | |
Share capital | Rs m | 224 | 224 | 224 | 224 | 224 | |
"Free" reserves | Rs m | 10,827 | 11,137 | 10,396 | 10,655 | 10,422 | |
Net worth | Rs m | 11,052 | 11,361 | 10,620 | 10,879 | 10,646 | |
Long term debt | Rs m | 1,656 | 1,215 | 1,282 | 2,911 | 2,265 | |
Total assets | Rs m | 27,050 | 26,333 | 23,758 | 23,880 | 21,686 | |
Interest coverage | x | 1.4 | 1.3 | 0.2 | 1.4 | 0.5 | |
Debt to equity ratio | x | 0.1 | 0.1 | 0.1 | 0.3 | 0.2 | |
Sales to assets ratio | x | 0.9 | 0.8 | 0.6 | 0.6 | 0.6 | |
Return on assets | % | 7.2 | 6.0 | 1.6 | 4.3 | 2.6 | |
Return on equity | % | 4.3 | 2.8 | -6.9 | 2.3 | -2.3 | |
Return on capital | % | 16.3 | 13.0 | 2.3 | 8.2 | 2.9 | |
Exports to sales | % | 43.7 | 42.4 | 54.3 | 47.2 | 62.0 | |
Imports to sales | % | 30.5 | 36.2 | 49.3 | 50.6 | 46.2 | |
Exports (fob) | Rs m | 10,715 | 8,865 | 7,188 | 6,669 | 8,064 | |
Imports (cif) | Rs m | 7,479 | 7,564 | 6,527 | 7,147 | 6,012 | |
Fx inflow | Rs m | 10,715 | 8,865 | 7,188 | 6,669 | 8,064 | |
Fx outflow | Rs m | 7,626 | 7,786 | 6,670 | 7,379 | 6,121 | |
Net fx | Rs m | 3,089 | 1,079 | 518 | -710 | 1,942 |
NECTAR LIFESCIENCE CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,392 | 2,850 | 214 | 950 | 1,337 | |
From Investments | Rs m | -261 | -331 | -286 | 166 | 517 | |
From Financial Activity | Rs m | -2,011 | -2,519 | 115 | -1,194 | -1,856 | |
Net Cashflow | Rs m | 120 | -0 | 42 | -77 | -2 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Sanjiv Goyal | COMP SEC: Anubha | YEAR OF INC: 1995 | BSE CODE: 532649 | FV (Rs): 1 | DIV YIELD (%): - |
Read: NECTAR LIFESCIENCE 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare NECTAR LIFESCIENCE With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets yesterday.